HSDT (Helius Medical Technologies Inc.) רווח סופי

Helius Medical is developing a business model that combines the sale of PoNS systems with high-margin SaaS support. The company is implementing neuromodulation in rehabilitation centers to assist in restoring motor skills. The primary challenges involve the struggle for insurance coverage and medical conservatism. The company's final net income confirms these fundamentals, with the figure reaching -0.16, helping investors filter out market noise.

This indicator tracks daily net income by measuring the difference between total revenues and all operating expenses to assess the actual efficiency of the business. By analyzing the overall profit of Helius Medical (HSDT), an investor can identify a critical working capital deficit caused by the slow adoption of the sole neurostimulator and challenges in securing insurance reimbursements.